Friday, July 17, 2026
Home Finance Its Dividend Looks Secure, But Don’t Chase JPM Stock After Q2 Earnings....

Its Dividend Looks Secure, But Don’t Chase JPM Stock After Q2 Earnings. Here’s Why.

0
2
SpaceX IPO Aftermath Hits Virgin Galactic Hard. How to Play SPCE Stock Here.


Bank earnings season is back, and JPMorgan Chase & Co. (JPM) just set the tone. The bank reported its Q2 2026 results on July 14, and the numbers were stronger than most expected a month ago.

JPMorgan Chase & Co. posted GAAP EPS of $7.70, beating estimates by 31.7% and well above the $5.24 from a year ago. Still, the stock fell about 2% in pre-market trading after the bank raised its 2026 expense outlook to $107.5 billion from $105 billion.

More News from Barchart

The stock had already been running up into the report, trading close to its 52-week high of $343.45. As the first major bank to report each quarter, JPM often sets the tone for the sector. It also continues to offer a solid dividend, with a $6.00 annual payout and a yield around 1.75%, backed by strong earnings and capital.

Now that earnings are out, where does JPMorgan Chase & Co. go next, and is the dividend enough reason to stay invested if upside looks limited?

Inside JPMorgan’s Latest Financials

JPMorgan Chase & Co. is a broad financial services company with businesses across consumer banking, investment banking, trading, asset management, and payments. It makes money from both interest income and fees, which helps keep things balanced.

The stock has been steady, up 21% over the past year and 7.57% year-to-date (YTD).

www.barchart.com

It is not cheap though, trading at a forward price-to-earnings ratio of 14,66 times versus the sector average of 11.34 times, showing investors are willing to pay a premium for its size and consistency.

For income investors, the appeal is clear. JPMorgan Chase & Co. pays a $6.00 annual dividend with a 1.75% yield, and the payout ratio is just 26.36%, leaving plenty of room for coverage. The bank has raised its dividend for 15 straight years and last paid $1.50 per share on July 6. It also approved a new $50 billion buyback program in late June and lifted its dividend by 10% after clearing the Federal Reserve stress test.

READ:   Palvella Therapeutics (PVLA) Submits Initial Module of NDA For QTORIN

The latest quarter backs all of this up. Revenue came in at $58.02 billion, up 27% year-over-year (YOY) and 13% above estimates, helped by strong equities trading. EPS was $7.70, beating expectations by 31.7%, while net income rose 41% to $21.2 billion, supported by gains from Visa shares and other investments. 



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here